Jennifer E Murray, Andrew W Walker, Robert J Polewan, Rick A Bevins
Index: Psychopharmacology 213 , 131-141, (2011)
Full Text: HTML
Research using a drug discriminated goal-tracking (DGT) task showed that the N-methyl-D: -aspartate (NMDA) channel blocker MK-801 (dizocilpine) reduced the nicotine-evoked conditioned response (CR).Given the unknown mechanism of the effect, Experiment 1 replicated the MK-801 results and included tests with NMDA receptor ligands. Experiments 2a and 2b tested whether MK-801 pretreatment blocked DGT via a state-dependency effect.In Experiment 1, adult male Sprague-Dawley rats received intermittent access to liquid sucrose following nicotine (0.4 mg base/kg); no sucrose was delivered on intermixed saline sessions. Conditioning was indicated by increased anticipatory dipper entries (goal-tracking) on nicotine compared to saline sessions. Antagonism and/or substitution tests were conducted with MK-801, phencyclidine, CGP 39551, d-CPPene (SDZ EAA 494), Ro 25,6981, L-701,324, ACPC, and NMDA. In Experiment 2a, rats received nicotine and sucrose on every session-no intermixed saline sessions without sucrose. Tests combined MK-801 or the non-competitive nicotinic acetylcholine receptor antagonist, mecamylamine with either nicotine or saline. Experiment 2b had sucrose delivered on saline sessions and no sucrose on intermixed nicotine sessions followed by MK-801 antagonism tests of the saline CS.MK-801 and phencyclidine dose-dependently attenuated the CR in Experiment 1. Ro-25,6981 enhanced the CR, but did not substitute for nicotine. Other ligands showed inconsistent effects. In Experiment 2a, MK-801 pretreatment reduced goal-tracking when given before nicotine and saline test sessions; mecamylamine pretreatment had no effect. In Experiment 2b, MK-801 dose-dependently attenuated the saline-evoked CR.Combined, the results suggest that MK-801 blocks discriminated goal-tracking by virtue of state-changing properties.
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
![]() |
L 701324
CAS:142326-59-8 |
C21H14ClNO3 |
|
NMDA/glutamate mechanism of magnesium-induced anxiolytic-lik...
2008-01-01 [Pharmacol. Rep. 60(5) , 655-63, (2008)] |
|
NMDA/glutamate mechanism of antidepressant-like action of ma...
2007-12-01 [Pharmacol. Biochem. Behav. 88(2) , 158-64, (2007)] |
|
Activation of the NMDA/glutamate receptor complex antagonize...
2007-01-01 [Pharmacol. Rep. 59(5) , 595-600, (2007)] |
|
Are glycineB sites involved in the development of morphine t...
2004-01-01 [Pol. J. Pharmacol. 56(1) , 51-7, (2004)] |
|
Activation of supraspinal NMDA receptors by both D-serine al...
2007-06-22 [Eur. J. Pharmacol. 565(1-3) , 89-97, (2007)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved
